Anti-CCD25/ CCDC25 monoclonal antibody

Anti-CCD25/ CCDC25 antibody for FACS & in-vivo assay

Target products collectionGo to CCDC25/CCDC25 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2394-Ab-1/ GM-Tg-hg-MP2394-Ab-2Anti-Human CCDC25 monoclonal antibodyHuman
GM-Tg-rg-MP2394-Ab-1/ GM-Tg-rg-MP2394-Ab-2Anti-Rat CCDC25 monoclonal antibodyRat
GM-Tg-mg-MP2394-Ab-1/ GM-Tg-mg-MP2394-Ab-2Anti-Mouse CCDC25 monoclonal antibodyMouse
GM-Tg-cynog-MP2394-Ab-1/ GM-Tg-cynog-MP2394-Ab-2Anti-Cynomolgus/ Rhesus macaque CCDC25 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2394-Ab-1/ GM-Tg-felg-MP2394-Ab-2Anti-Feline CCDC25 monoclonal antibodyFeline
GM-Tg-cang-MP2394-Ab-1/ GM-Tg-cang-MP2394-Ab-2Anti-Canine CCDC25 monoclonal antibodyCanine
GM-Tg-bovg-MP2394-Ab-1/ GM-Tg-bovg-MP2394-Ab-2Anti-Bovine CCDC25 monoclonal antibodyBovine
GM-Tg-equg-MP2394-Ab-1/ GM-Tg-equg-MP2394-Ab-2Anti-Equine CCDC25 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2394-Ab-1/ GM-Tg-hg-MP2394-Ab-2; GM-Tg-rg-MP2394-Ab-1/ GM-Tg-rg-MP2394-Ab-2;
GM-Tg-mg-MP2394-Ab-1/ GM-Tg-mg-MP2394-Ab-2; GM-Tg-cynog-MP2394-Ab-1/ GM-Tg-cynog-MP2394-Ab-2;
GM-Tg-felg-MP2394-Ab-1/ GM-Tg-felg-MP2394-Ab-2; GM-Tg-cang-MP2394-Ab-1/ GM-Tg-cang-MP2394-Ab-2;
GM-Tg-bovg-MP2394-Ab-1/ GM-Tg-bovg-MP2394-Ab-2; GM-Tg-equg-MP2394-Ab-1/ GM-Tg-equg-MP2394-Ab-2
Products NameAnti-CCDC25 monoclonal antibody
Formatmab
Target NameCCDC25
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCDC25 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CCD25/ CCDC25 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003088human CCDC25 Lentivirus plasmid
    ORF Viral VectorvGMLP003088human CCDC25 Lentivirus particle
    ORF Viral VectorpGMLPm002413mouse Ccdc25 Lentivirus plasmid
    ORF Viral VectorvGMLPm002413mouse Ccdc25 Lentivirus particle


    Target information

    Target IDGM-MP2394
    Target NameCCDC25
    Gene ID55246,67179,361059,718295,612822,101080530,507275,100060683
    Gene Symbol and Synonyms2610528H13Rik,CCDC25,NSrp70,RGD1307689
    Uniprot AccessionQ86WR0,Q3SZX8
    Uniprot Entry NameCCD25_HUMAN,CCD25_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000147419
    Target ClassificationN/A

    The target: CCDC25, gene name: CCDC25, also named as . Enables DNA binding activity. Involved in positive regulation of cell motility. Located in endomembrane system. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.